Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.6M Buy
147,055
+131,218
+829% +$12.4M 0.21% 80
2026
Q1
$1.87M Buy
+15,837
New +$1.96M 0.04% 743
2025
Q4
Sell
-84,902
Closed -$12.4M 2055
2025
Q3
$12.4M Buy
84,902
+25,889
+44% +$3.91M 0.3% 51
2025
Q2
$9.2M Buy
59,013
+46,501
+372% +$7.37M 0.23% 81
2025
Q1
$2.06M Sell
12,512
-9,155
-42% -$1.52M 0.14% 185
2024
Q4
$3.53M Buy
+21,667
New +$3.87M 0.24% 98
2024
Q2
Sell
-16,027
Closed -$2.71M 2001
2024
Q1
$2.71M Buy
+16,027
New +$3M 0.2% 108
2023
Q4
Sell
-16,606
Closed -$2.89M 1719
2023
Q3
$2.89M Buy
+16,606
New +$3.02M 0.28% 73
2023
Q2
Sell
-2,653
Closed -$442K 1797
2023
Q1
$442K Sell
2,653
-1,452
-35% -$238K 0.05% 600
2022
Q4
$602K Sell
4,105
-23,837
-85% -$3.53M 0.09% 364
2022
Q3
$4.14M Buy
+27,942
New +$4.67M 0.41% 29
2022
Q2
Sell
-3,534
Closed -$666K 1244
2022
Q1
$666K Buy
+3,534
New +$699K 0.15% 192
2021
Q4
Sell
-5,529
Closed -$1.07M 933
2021
Q3
$1.07M Buy
+5,529
New +$1.12M 0.2% 170
2021
Q1
Sell
-2,253
Closed -$370K 843
2020
Q4
$370K Buy
+2,253
New +$366K 0.16% 246

Other funds holding ZTS

Y-Intercept (HK)'s ZTS Position: Q2 2026 in Review

Y-Intercept (HK) increased its Zoetis (ZTS) stake by 829% in Q2 2026, buying an estimated $12.4M and bringing the position to 147,055 shares worth $10.6M. The position accounts for 0.21% of the portfolio, ranked #80.

Y-Intercept (HK) first reported a position in ZTS in Q4 2020 and has held it in 14 quarters since. The position peaked at $12.4M in Q3 2025. 308 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Y-Intercept (HK) held 147,055 shares of Zoetis worth $10.6M as of Q2 2026.
  • Y-Intercept (HK) bought 131,218 Zoetis shares in Q2 2026, an estimated $12.4M.
  • Zoetis made up 0.21% of Y-Intercept (HK)'s portfolio in Q2 2026, its #80 holding.
  • Y-Intercept (HK) first reported a position in Zoetis in Q4 2020 and has held it in 14 quarters since.
  • Y-Intercept (HK)'s Zoetis position peaked at $12.4M in Q3 2025.
  • 308 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.